Skip to Main Content
Table 1—

Significance testing between young-onset type 2 diabetic subjects and Alström syndrome subjects with diabetes

ParameterAlström syndrome with no diabetesAlström syndrome with diabetesType 2 diabetesType 2 diabetes vs. Alström syndrome with diabetes (P)
n 18 40 30  
Neuropathic symptoms (%) 30.1 <0.0001 
Perception     
    all 2-g monofilament (%) 80 95 36 0.001 
    all 10-g monofilament (%) 100 100 38 0.001 
    128-MHz vibration (%) 100 97 72 0.004 
Neuropathy (%) 34.6 0.0006 
Foot ulceration <0.0001 
ParameterAlström syndrome with no diabetesAlström syndrome with diabetesType 2 diabetesType 2 diabetes vs. Alström syndrome with diabetes (P)
n 18 40 30  
Neuropathic symptoms (%) 30.1 <0.0001 
Perception     
    all 2-g monofilament (%) 80 95 36 0.001 
    all 10-g monofilament (%) 100 100 38 0.001 
    128-MHz vibration (%) 100 97 72 0.004 
Neuropathy (%) 34.6 0.0006 
Foot ulceration <0.0001 

The Kruskal-Wallis test for monofilament perception and Fisher's exact test for 128 V (128-MHz tuning fork perception) were used. See text for definition of neuropathy and characteristics of symptoms.

Close Modal

or Create an Account

Close Modal
Close Modal